Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Stem cell serum effectively treated hair loss caused by COVID-19.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Minoxidil is effective and safe for hair growth in Androgenetic Alopecia, with manageable side effects.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Most patients stop using topical minoxidil due to side effects.

The hemp extract significantly increased hair regrowth in both men and women without any side effects.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Podcasting could improve dermatology education if it had more consistent, evidence-based content and better regulation.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

Baby born healthy despite mom taking finasteride, but more research needed.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Found 32 genes linked to male baldness, affecting hair growth and stress-related pathways.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Targeted cancer therapies often cause serious skin problems that need careful management.

Wound healing insights can improve regenerative medicine.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.